Audrain J, Rimer B, Cella D, Garber J, Peshkin B N, Ellis J, Schildkraut J, Stefanek M, Vogel V, Lerman C
Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.
J Clin Oncol. 1998 Jan;16(1):133-8. doi: 10.1200/JCO.1998.16.1.133.
To assess preferences for the content and process of genetic counseling and testing for breast-ovarian cancer susceptibility among women at high risk for breast cancer.
Ninety-eight healthy women who had a family history of breast cancer in at least two first-degree relatives participated in a structured telephone survey that evaluated preferences for type of provider and the content and process of pretest education and posttest genetic counseling.
Forty-two percent of women preferred that pretest education be delivered by a genetic counselor, while 22% preferred an oncologist. This preference was positively associated with a desire to discuss psychosocial issues during the session (P = .001). For posttest counseling, 38% of women preferred an oncologist, while 20% preferred a genetic counselor. However, women who desired supportive counseling during this session were significantly more likely to prefer a genetic counselor to an oncologist (P = .02). Fewer women wished to see a primary care physician or gynecologist for pretest education (11%) or posttest counseling (22%). With regard to the counseling process, 82% of women wished to self-refer for genetic counseling, but 63% desired advice and recommendations about whether to be tested.
When feasible, the optimal approach may be for oncologists to work with genetic counselors to provide pretest education and medical recommendations. Elicitation of patients' preferences may be useful to determine the level of counseling services needed.
评估乳腺癌高危女性对乳腺癌 - 卵巢癌易感性基因咨询和检测的内容及流程的偏好。
98名在至少两名一级亲属中有乳腺癌家族史的健康女性参与了一项结构化电话调查,该调查评估了她们对咨询提供者类型以及检测前教育和检测后基因咨询的内容及流程的偏好。
42%的女性希望由基因咨询师提供检测前教育,而22%的女性希望由肿瘤学家提供。这种偏好与在咨询过程中讨论心理社会问题的意愿呈正相关(P = .001)。对于检测后咨询,38%的女性希望由肿瘤学家进行,而20%的女性希望由基因咨询师进行。然而,在此阶段希望获得支持性咨询的女性明显更倾向于选择基因咨询师而非肿瘤学家(P = .02)。较少女性希望在检测前教育(11%)或检测后咨询(22%)时咨询初级保健医生或妇科医生。关于咨询流程,82%的女性希望自行转诊进行基因咨询,但63%的女性希望获得关于是否进行检测的建议和推荐。
在可行的情况下,最佳方法可能是肿瘤学家与基因咨询师合作,提供检测前教育和医疗建议。了解患者的偏好可能有助于确定所需的咨询服务水平。